Agilent Technologies (NYSE:A) Releases Q3 2026 Earnings Guidance

Agilent Technologies (NYSE:A) updated its third quarter 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.480-1.500 for the period, compared to the consensus estimate of 1.500. The company issued revenue guidance of $1.8 billion-$1.9 billion, compared to the consensus revenue estimate of $1.8 billion. Agilent Technologies also updated its FY 2026 guidance to 6.000-6.100 EPS.

Analyst Upgrades and Downgrades

A has been the topic of a number of recent research reports. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a report on Thursday, February 26th. Wall Street Zen lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. UBS Group dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Royal Bank Of Canada assumed coverage on Agilent Technologies in a research note on Wednesday. They issued an “outperform” rating and a $153.00 price target on the stock. Finally, Barclays lowered their target price on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Two analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of “Buy” and a consensus target price of $162.40.

Agilent Technologies Stock Up 0.6%

Shares of A traded up $0.74 on Wednesday, reaching $115.82. The company’s stock had a trading volume of 2,339,395 shares, compared to its average volume of 2,182,175. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. Agilent Technologies has a twelve month low of $108.35 and a twelve month high of $160.27. The stock has a market capitalization of $32.73 billion, a PE ratio of 25.57, a PEG ratio of 2.42 and a beta of 1.22. The firm has a fifty day moving average of $114.91 and a 200-day moving average of $129.01.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter in the prior year, the business earned $1.31 EPS. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. Equities analysts predict that Agilent Technologies will post 5.95 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies’s dividend payout ratio (DPR) is 22.52%.

Institutional Investors Weigh In On Agilent Technologies

Several large investors have recently added to or reduced their stakes in A. Brighton Jones LLC increased its holdings in Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after acquiring an additional 270 shares during the last quarter. Jones Financial Companies Lllp increased its holdings in Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after acquiring an additional 769 shares during the last quarter. Geneos Wealth Management Inc. increased its holdings in Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after acquiring an additional 212 shares during the last quarter. Acadian Asset Management LLC increased its holdings in Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after acquiring an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in Agilent Technologies in the 2nd quarter worth about $273,000. Hedge funds and other institutional investors own 87.41% of the company’s stock.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.